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Abstract 
BACKGROUND: The present study aimed to assess the factors associated with the mortality of patints with brain 
tumor surgery at Be’sat Hospital in Sanandaj, Kurdistan, Iran. 
METHODS: In this prospectively cross-sectional study, 108 patients diagnosed with brain tumor and followed by a 
surgery during April to December of 2014 were recruited. Eighteen cases were excluded from the study due to lack 
of information about their treatment outcomes. Patients’ information including age, gender, tumor type, tumor 
location, type of treatment, and extent of resection was collected by a checklist. Clinical outcome of the patients in 
six months after surgery was determined through phone calling to patients. All analyses conducted in SPSS 
software using logistic regression. 
RESULTS: Forty-seven (52.2%) of the studied subjects were women. The age of cases ranged from 3 to 83 years 
with total mean of 43.4 ± 21.9 years. In six months after treatment, 41 (45.6%) of the treated patients died. 
After excluding 9 children from final analysis and modeling the data by logistic regression, statistically significant 
associations were observed between death from central nervous system (CNS) tumor and male gender [odds 
ratio (OR): 5.25, 95% confidence interval (CI): 1.38–21.99], higher age (OR: 1.07, 95% CI: 1.02–1.13), partial 
vs. total resection (OR: 20.24, 95% CI: 1.21–337.51), and high malignant potential tumors (OR: 14.77, 95% CI: 
4.85–45.02). 
CONCLUSION: The results showed that both demographic (advanced age and male gender) and clinical factors 
(high malignant potential tumors and partial removal of tumor) related to the worse outcome in patients with 
primary CNS tumors during six months after surgery. 
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Nearly a hundred histologically distinct types 
of primary central nervous system (CNS) 
tumors have been recognized, each of them 
having its own spectrum of clinical 




presentations, treatments, and outcomes. 
Primary brain tumors are divided into benign 
and malignant tumors that originate directly 
from the brain and its appendages.1,2 The 
incidence of brain tumors has increased in all 
age groups over the past two decades. 
According to the central brain tumor registry 
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rate of all primary malignant and non-
malignant brain and CNS tumors was 21.97 
cases per 100000 for a total count of 356858 
incident tumors diagnosed during 2015 in the 
United States of America (USA).3,4 The 
estimated number of new cases with brain and 
other nervous system tumors has been 
reported 23770 (7.3 per 100000) with 16050 
deaths (fatality rate: 67.5%) in 2016.5 
Although primary malignant CNS tumors 
are now registered in the national cancer 
registry (NCR) of Iran, there is no availability 
of nationwide CNS tumor epidemiologic data 
due to failure in surveillance system and 
incompleteness of collected data. Based on two 
previous review studies, the annual incidence 
of primary brain tumors in Iran is estimated to 
be 2.70 to 5.69 per 100000.6,7 
Brain tumor can occur in both genders at 
any age, but its incidence and histology is 
different between age and sex groups. There is 
a modest rise before age 10 and a steady 
increase after age 15, with a maximum 
incidence between 75 and 84 years age group. 
Based on USA statistics, the incidence and 
mortality of brain and other nervous system 
tumors is higher in men. Furthermore, the 
incidence of all brain tumors, except 
meningioma, is higher in men.5 Surgery is 
important to remove a large tumor, but large 
tumor resection has more risk than small 
tumors. Although complementary treatments 
such as radiotherapy and chemotherapy are 
beneficial because of their high precision, they 
have some limitations.7,8  
Albeit emergence of new diagnostic and 
therapeutic techniques led to improvement in 
treatment of brain tumors, high mortality after 
surgery or combination therapy is still a 
challenging issue for neurosurgeons that can 
be influenced by different factors. According to 
the exiting evidence, demographic variables, 
such as age and gender, and clinical factors 
such as tumor characteristics (type, size, grade, 
stage, and location), extent of surgical 
resection, skills of surgeon, and also pre- and 
post-operative cares should be seriously 
considered.9-11  
As mentioned earlier, the follow-up of 
patients with brain tumor after surgery to 
determine the outcome and assessing the 
potential related factors is essential. The aim of 
this study was to assess the potential risk factors 
related to the mortality in patients with brain 
and CNS tumors in six months after surgery. 
Materials and Methods 
In this prospectively cross-sectional study, all 
patients diagnosed with brain tumor during 
2014 that underwent treatment (surgery) of 
tumor at Be'sat Hospital in Sanandaj, Iran, 
were investigated. The total number of 
patients included in the study was 108 
individuals, primarily. Eighteen patients were 
excluded from the study due to lack of 
information about their treatment outcomes.  
Data were collected using a checklist from 
patient medical records that was archived in 
the hospital. Patient information including age, 
gender, tumor type, tumor location, type of 
treatment, and extent of resection was 
extracted from patient’s medical records. 
Clinical outcome, and death or survival 
(relative/complete cure) of each patient was 
obtained in six months after surgery follow-up 
by phone calls to either the patient or her/his 
family. It should be noted that during fallow-
up and calling to the patients, the aim of the 
research was explained and oral informed 
consent for data collection was taken from all 
individuals who entered in the study.  
All analyses were conducted in SPSS 
software (version 20, IBM Corporation, 
Armonk, NY, USA). In analyzing the data, we 
first used independent sample t-test and chi 
square to assess the relation between studied 
variables, death, and studied outcome; then 
the values of odds ratio (OR), corresponding 
95% confidence interval (CI) for OR, and 
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factor using logistic regression method. 
It was noted that after the description of 
patients’ characteristics and in order to 
determine the association between studied 
factors and mortality in six months after brain 
tumor surgery, 9 children aged < 15 years were 
excluded from the analysis due to the 
differences between children and adult  
brain tumors. 
Results 
A total of 108 patients diagnosed with brain 
tumor and followed by a surgery during 2014 
were recruited. Eighteen cases were excluded 
from the study due to lack of information 
about their treatment outcomes. The mean  
age ± standard deviation (SD) for other 
remaining subjects (90 patients) was 43.4 ± 21.9 
years. They spanned from 3 to 83 years old, 
and 52.2% of them were female. More patients 
(98%) were Iranian Kurds ethnically. The most 
common type of diagnosed tumors was 
meningioma (37.8%). Furthermore, 74.4% of 
tumor site was supratentorial. For 71% of 
patients, surgery without any supplementary 
treatment was the only treatment option, 
whereas 29% had an additional treatment after 
surgery. Additional or complementary 
treatments were chemotherapy, radiotherapy, 
or both chemotherapy and radiotherapy. For 
87.8%, the total surgical procedure was 
performed. In terms of treatment outcome, 
22.2% of cases had complete response, 32.2% 
had partial response, and 45.6% died. Table 1 
displays more details of patient characteristics 
in the study. 
 
Table 1. Demographic and clinical characteristics of studied patients 
Variables 
All patients 
 (n = 90) 
Cases aged ≥ 15 years 
 (n = 81) 
Age (Mean ± SD) 43.40 ± 21.96 47.50 ± 19.16 
Gender [n (%)]   
Female 47 (52.2) 44 (54.3) 
Male 43 (47.8) 37 (45.7) 
Surgical resection [n (%)]   
Partial 11 (12.2) 9 (11.1) 
Total 79 (87.8) 72 (88.9) 
Treatment type [n (%)]   
Surgery 64 (71.1) 62 (76.5) 
Surgery + chemotherapy 6 (6.7) 4 (4.9) 
Surgery + radiotherapy  7 (7.8) 7 (8.6) 
Surgery + radiotherapy + chemotherapy 13 (14.4) 8 (9.9) 
Tumor location [n (%)]   
Infra tentorial 23 (25.6) 15 (18.5) 
Supra tentorial 67 (74.4) 66 (81.5) 
Tumor type [n (%)]   
Meningioma 34 (37.8) 33 (40.7) 
Glioblastoma 21 (23.3) 21 (25.9) 
Astrocytoma  12 (13.3) 10 (12.3) 
Ependymoma 8 (8.9) 6 (7.4) 
Medulloblastoma 4 (4.4) - 
Schwannoma 4 (4.4) 4 (4.9) 
Pituitary adenoma 3 (3.3) 3 (3.7) 
Colloid cyst  2 (2.2) 2 (2.5) 
Craniopharyngioma  1 (1.1) 1 (1.2) 
Choroid plexus papilloma 1 (1.1) 1 (1.2) 
Outcome [n (%)]   
Death 41 (46.0) 36 (44.4) 
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Table 2. Association between clinical outcome and demographic and clinical variables (n = 81) 
Variables 
Cured (relatively or 
completely cured), [n (%)] 
Died, 
[n (%)] 
P OR (95% CI) 
Gender   < 0.001 6.25 (2.37–16.47) 
Female 33 (75.0) 11 (25.5)   
Male 12 (32.4) 25 (67.6)   
Surgical resection    0.004 12.57 (1.49–106.02) 
Total 44 (61.1) 28 (38.9)   
Partial 1 (11.1) 8 (88.9)   
Treatment type   0.020 - 
Surgery 38 (61.3) 24 (38.7)   
Surgery + chemotherapy 0 (0.0) 4 (100.0)   
Surgery + radiotherapy  5 (71.4) 2 (28.6)   
Surgery + radiotherapy + chemotherapy 2 (25.0) 6 (75.0)   
Tumor location   0.100 0.39 (0.11-1.34) 
Infra tentorial 11 (73.3) 4 (26.7)   
Supra tentorial 34 (51.5) 32 (48.5)   
Tumor type   0.001 4.92 (1.91–12.68) 
Potentially low malignant tumors  
(Meningioma, Schwannoma, and others) 
32 (72.7) 12 (27.3)   
Potentially high malignant tumors 
(Glioblastoma, Astrocytoma, Ependymoma) 
          13 (35.1) 24 (64.9)   
Age (Mean ± SD) 47.1 ± 16.8 48.0 ± 22.0 0.800
*
  
OR: Odds ratio; CI: Confidence interval; * Independent t test result 
 
Since 9 patients from all 90 studied patients 
were children aged less than 13 years, we 
excluded them in univariate and multivariate 
analysis, and information from 81 remaining 
patients was analyzed. Table 2 summarizes the 
univariate analysis to assess the relationship 
between clinical outcomes of studied patients 
with demographic and clinical factors in  
81 patients. 
As shown in table 2, death from brain tumor 
six months after surgery was significantly 
associated with gender (P < 0.001), surgical 
resection (P = 0.004), treatment type (P = 0.020) 
and tumor type (P = 0.001). 
In order to control potential confounders, the 
logistic regression model was performed. The 
OR, corresponding 95% CI, and significance 
values for each factor were calculated (Table 3). 
As shown in table 3, although three 
variables including male gender (P < 0.001), 
partial resection of surgery (P = 0.020), and 
potentially high malignant tumors (P < 0.001) 
were significantly associated with death in six 
months after brain surgery in univariate 
analysis, two demographic factors including 
higher age (P = 0.010), male gender (P = 0.010), 
and also two clinical factors, potentially high 
malignant tumors (P < 0.001) and partial 
resection of tumor (P = 0.030), were significant 
factors in the final model. 
Discussion 
In the present study, we followed all patients 
with brain tumors that underwent surgery and 
other complementary treatments for six 
months after surgery. Our results showed that 
45.6% of studied patients were dead. Higher 
age, male gender, potentially high malignant 
tumors, and partial resection were four 
significant factors associated with mortality of 
patients with CNS tumors after treatment.  
The results indicated that the chance of death 
from brain tumors after treatment increased with 
increasing age. The association between higher 
age and death in patients treated for CNS tumors 
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Table 3. Logistic regression results for variables associated with mortality in patients with brain tumor  
Variable 
Crude Adjusted 
OR (95% CI) P OR (95% CI) P 
Age 1.01 (0.98–1.03) 0.800 1.07 (1.02–1.13) 0.010 
Gender     
Female - - - - 
Male 6.25 (2.37–16.47) < 0.001 5.52 (1.38–21.99) 0.010 
Surgical resection      
Total - - - - 
Partial 12.57 (1.49–106.02) 0.020 20.24 (1.21–337.51) 0.030 
Treatment type     
Surgery - - - - 
Surgery + chemotherapy 0.22 (0.04–1.16) 0.070 0.11 (0.01–1.05) 0.050 
Surgery + radiotherapy  1.33 (0.09–20.12) 0.800 0.63 (0.01–30.05) 0.800 
Surgery + radiotherapy + chemotherapy 0.13 (0.01-1.32) 0.080 0.07 (0.01–1.23) 0.070 
Tumor location     
Infra tentorial - - - - 
Supra tentorial 2.59 (0.75–8.96) 0.100 0.77 (0.17–3.57) 0.700 
Tumor type     
Potentially low malignant tumors 
(Menengioma, Schwannoma, and others)  
- - - - 
Potentially high malignant tumors 
(Glioblastoma, Astrocytoma, Ependymoma) 
4.92 (1.91–12.68) < 0.001 14.77 (4.85–45.02) < 0.001 
OR: Odds ratio; CI: Confidence interval 
 
Reihani Kermani reported higher mortality 
rate for elderly patients.7 Similar findings have 
also been reported in some studies;12,13 for 
example, Tian et al. in a systematic review 
study indicated that higher age was a main 
risk factor for CNS cancers and its related 
death.14 Age was also significantly associated 
with survival of patients in Stark et al. study.15 
Some studies have reported different results 
about the effect of patients’ age on CNS 
surgery outcome, so in previous studies 
conducted on patients with glioblastoma, 
higher age was a prognostic factor for patients 
undergoing biopsy while not an effective 
factor in patients undergoing resection.16,17  
According to the results, male gender was 
another significant factor for death in patients 
with CNS tumors undergoing surgery. Some 
previous studies support this finding.1,3,18,19 In 
a study conducted by Villano et al., it was 
shown that male gender was a risk factor for 
death outcome from primary CNS lymphoma 
in patients with age less than 50 years. They 
also concluded that advanced age was only a 
significant risk factor for survival of these 
patients in +50 age groups.20  
In addition to above mentioned 
demographic variables, two clinical factors 
including having tumors with high malignant 
potential and partial surgical resection of tumor 
were recognized as main risk factors for patient 
mortality after treatment. There are several 
studies about surgical resection type, partial or 
total resection, as predictor factor for treatment 
outcome in treated patients with CNS tumors. 
Johnson et al. showed that total resection was a 
positive prognostic factor.21 Song et al. indicated 
that complete removal of tumor provided the 
best outcome. However, without 
complementary therapy, the outcome does not 
seem to be desirable.22 The same conclusion 
about the association of total resection and 5-
year survival of pineocytoma has also been 
reported by Clark et al.23 In another study 
conducted by Chaichana et al., subtotal 
resections have been reported as independent 
risk factors for visual outcome and tumor 
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meningioma.24 Oszvald et al. recommended 
total resection plus adjuvant therapy in elderly 
patients with malignant brain tumor.25 
There are several earlier supportive studies 
regarding another significant clinical risk 
factor, i.e. tumors with high malignant 
potential, that had highest association  
(OR = 14.77) with patients’ mortality in our 
study.26-28 Our results showed that the chance 
of death in patients with high malignant 
potential tumors was approximately 15 times 
higher than patients with low malignant 
potential tumors. Higher mortality resulting 
from malignant versus benign CNS tumors has 
been reported as an acceptable issue in many 
previous studies.29-31 Although, anatomical 
positions and specific conditions of the CNS 
tumors may lead to life threatening 
complications even in benign tumors,32,33 our 
findings demonstrated that tumor malignancy 
was the strongest risk factor for death in 
patients with CNS tumors after modeling the 
data and controlling the potential confounders.  
Location of tumor (infra or supra tentorial) 
and type of treatment (surgery or combination 
of surgery plus radiotherapy or/and 
chemotherapy) had no statistical association 
with mortality in our study; whereas, there is 
some evidence about the effect of these factors 
in the literature that is incompatible with our 
results. Bagley et al. demonstrated that 
patients with supratentorial tumors had 
shorter survival time than those with 
infratentorial tumors.34 Two other studies 
advocated this finding.15,35 In Stark et al. study, 
prolonged survival was associated with 
patients undertaking several treatments 
(radiotherapy, chemotherapy, and combined 
radio-/chemotherapy with temozolomide).15 
We did not observe any association between 
treatment type as a risk factor and mortality. 
The choice of the type of treatment by 
neurosurgeon depends on the clinical 
condition of the patient. Meeske and Nelson 
suggested combination treatment in patients 
with partial resection to remove residual 
tumor or tumor recurrence treatment.10 
The main limitation of the present study was 
lack of full access to information on 
socioeconomic status (SES), body mass index 
(BMI), life styles, and geographic location of 
patients; whereas, some past studies have 
shown that these factors can play a significant 
role on post-surgery survival in both adults and 
children. Other limitations of the study were 
small sample size, cross-sectional analysis, and 
non-generalizability of the results. 
Conclusion 
In this study, we investigated the clinical 
outcome of treated patients with CNS tumors 
in six months after surgery in Sanandaj. The 
results showed that two demographic 
(advancing age and male gender) and two 
clinical factors (high malignant potential 
tumors and partial removal of tumor) were 
associated with higher mortality. 
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